MedPage Today (11/23, DePeau-Wilson) reported, “Use of medications for” attention-deficit/hyperactivity disorder (AD/HD) “was not associated with increased cardiovascular disease (CVD) risk,” investigators concluded in the findings of a 19-study systematic review and meta-analysis published online Nov. 23 in JAMA Network Open. The researchers found that “among over 3 million people, there were no statistically significant associations between AD/HD medication use and any CVD risks among children and adolescents…young or middle-age adults…or older adults…over a median follow-up ranging from 0.25 to 9.5 years.”
Related Links:
— MedPage Today (requires login and subscription)